000			01693nam a2200361Ia 4500
001			ebr10606369
003			CaPaEBR
007			cr cn|||||||||
008			111220s2012 dcua sb 000 0 eng d
020			_z9780309253154
020			_z0309253152
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)813396119
050	1	4	_aR853.C55 _bE585 2012eb
245	0	0	_aEnvisioning a transformed clinical trials enterprise in the United States _h[electronic resource] : _bestablishing an agenda for 2020: workshop summary / _cNeil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
260			_aWashington : _bNational Academies Press, _c2012.
300			_axvi, 232 p. : _bill.
504			_aIncludes bibliographical references.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2011. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aClinical trials _zUnited States.
650		0	_aClinical medicine _xResearch _zUnited States.
655		7	_aElectronic books. _2local
700	1		_aWeisfeld, Neil E.
700	1		_aEnglish, Rebecca A.
700	1		_aClaiborne, Anne B.
710	2		_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation.
710	2		_aInstitute of Medicine (U.S.). _bBoard on Health Sciences Policy.
710	2		_aNational Academies Press (U.S.)
710	2		_aebrary, Inc.
856	4	0	_uhttp://site.ebrary.com/lib/kliuc/Doc?id=10606369 _zAn electronic book accessible through the World Wide Web; click to view
942			_2lcc _cEBK
999			_c221444 _d221444